Merit Medical Systems, Inc. (MMSI) reported third-quarter 2024 adjusted earnings per share (EPS) of 86 cents, up 21.1% from the year-ago quarter. The bottom line surpassed the Zacks Consensus Estimate by 7.5%.GAAP EPS for the quarter was 48 cents, up 9.1% year over year.Find the latest EPS estimates and surprises on Zacks Earnings Calendar.MMSI’s Revenue DetailsRevenues grossed $339.8 million in the reported quarter, up 7.8% year over year. The metric topped the Zacks Consensus Estimate by 1.4%.Total revenu ...

Merit Medical (MMSI) reported $339.85 million in revenue for the quarter ended September 2024, representing a year-over-year increase of 7.8%. EPS of $0.86 for the same period compares to $0.75 a year ago. View all Key Company Metrics for Merit Medical here>>> The reported revenue represents a surprise of +1.44% over the Zacks Consensus Estimate of $335.02 million. With the consensus EPS estimate being $0.80, the EPS surprise was +7.50%. While investors closely watch year-over-year changes in headline numbe ...

Merit Medical (MMSI) came out with quarterly earnings of $0.86 per share, beating the Zacks Consensus Estimate of $0.80 per share. This compares to earnings of $0.75 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of 7.50%. A quarter ago, it was expected that this maker of disposable medical devices would post earnings of $0.88 per share when it actually produced earnings of $0.92, delivering a surprise of 4.55%. Over the last f ...

Exhibit 99.1 1 | --- | --- | --- | |-------|---------------------------------------------------------------------------------------------------|-----------------------------------------------------------------------------------------------------------------------| | | | | | | Contacts: | | | | PR/Media Inquiries: Sarah Comstock Merit Medical +1-801-432-2864 sarah.comstock@merit.com | Investor Inquiries: Mike Piccinino, CFA, IRC Westwicke – ICR +1-443-213-0509 mike.piccinino@westwicke.com | FOR IMMEDIATE REL ...

If you are looking for a stock that has a solid history of beating earnings estimates and is in a good position to maintain the trend in its next quarterly report, you should consider Merit Medical (MMSI) . This company, which is in the Zacks Medical - Dental Supplies industry, shows potential for another earnings beat.This maker of disposable medical devices has an established record of topping earnings estimates, especially when looking at the previous two reports. The company boasts an average surprise f ...

SOUTH JORDAN, Utah, Oct. 08, 2024 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading global manufacturer and marketer of healthcare technology, announced today that it will release its financial results for the quarter ended September 30, 2024, after the close of the stock market on Wednesday, October 30, 2024. Contacts: Merit will hold its investor conference call on the same day (Wednesday, October 30, 2024) at 5:00 p.m. Eastern (4:00 p.m. Central, 3:00 p.m. Mountain, and 2:00 p.m. ...

Merit Medical Systems, Inc. (MMSI) witnessed strong momentum in the year-to-date period. Shares of the company have rallied 24.7% against the industry's decline of 1.6%. The S&P 500 composite has risen 20.8% in the same period. With healthy fundamentals and strong growth opportunities, this Zacks Rank #3 (Hold) company appears to be a solid wealth creator for its investors at the moment. Merit Medical provides various peripheral and cardiac intervention products to cure cardiac conditions specific to interv ...

Merit Medical Systems, Inc. (MMSI) is well poised for growth in the coming quarters, courtesy of its strong product portfolio. The optimism, led by solid second-quarter 2024 performance and its continued spending on research and development (R&D), is expected to contribute further. However, headwinds due to higher consolidation in the healthcare industry and forex volatility persist. This Zacks Rank #3 (Hold) company has gained 26.6% in the past six months against the 7.8% decline of the industry.The S&P 50 ...

Merit Medical Systems, Inc. (MMSI) , on Tuesday, signed a definitive asset purchase agreement to purchase Cook Medical's lead management portfolio for a total cash consideration of approximately $210 million. The acquisition is consistent with MMSI's Continued Growth Initiatives and should position the company to offer clinicians an increasingly comprehensive set of solutions to support cardiac intervention patients, ranging from diagnosis to post-procedure care. The closing of the proposed transaction is e ...

Acquisition and Financial Impact - Merit Medical signed an agreement to purchase Cook Medical's lead management portfolio for approximately $210 million, expected to close in Q4 2024[1]. - The acquisition is projected to add approximately $40 million in annual revenue starting in fiscal year 2025, enhancing Merit's electrophysiology and CRM business[1]. - The acquisition is expected to be modestly dilutive to Merit's full-year 2024 non-GAAP profitability due to partial-year contribution[4]. - The acquisition is projected to be accretive to non-GAAP gross margin and operating margin in the first full year post-close[5]. - Merit anticipates the acquisition will enhance its position in the cardiac intervention market, contributing to over $100 million in combined annualized revenue[3]. - The financial profile of the acquisition is considered attractive, aligning with Merit's goal of sustainable growth and strong free cash flow generation[4]. Financial Guidance and Performance - The updated full-year 2024 financial guidance reflects net sales of $1.339 - $1.351 billion, a year-over-year increase of 6.5% - 7.5%[6]. - Non-GAAP earnings per share guidance for 2024 is projected at $3.25 - $3.34, representing a year-over-year increase of 14% - 17%[6]. - Cook Medical's lead management business generated approximately $37 million in revenue for the twelve months ending December 31, 2023, with sales distribution of 41% in the US, 42% in EMEA, 11% in APAC, and 6% in ROW[5]. Market Opportunities and Challenges - The cardiac intervention market represents an annual addressable opportunity of over $900 million in the US, EMEA, and APAC regions[3]. - The company is aware of the risks associated with market acceptance of new products and competition in the medical device industry[23]. - Merit Medical's financial results are subject to various uncertainties, including supply chain disruptions and changes in economic conditions[23]. Compliance and Regulatory Considerations - The company is actively pursuing new product development and regulatory approvals, particularly under the European Union Medical Device Regulation[23]. - Merit Medical faces potential challenges related to compliance with healthcare regulations and the impact of governmental scrutiny on its operations[23]. - The company is committed to maintaining high standards of quality and ethics in its medical device offerings[21]. Strategic Focus and Relationships - Merit Medical's growth strategy includes managing acquisitions effectively and integrating new technologies[23]. - The company emphasizes the importance of its relationships with suppliers and distributors in various jurisdictions[23]. - The company anticipates achieving projected sales and operating margins post-acquisition, although there are risks associated with integration and market conditions[23]. - Merit Medical's financial estimates and forward-looking statements are subject to change and should not be relied upon as definitive predictions[22].